TCTR20190707002招募中2 期
Effects of genetic polymorphism of CYP3A5 and UGT1A9 in brain-death donor andliver transplant recipients on pharmacokinetic profiles of tacrolimus andmycophenolate at steady state post-transplantation
Rachadapisek Sompote Fund.0 个研究点目标入组 20 人开始时间: 2019年7月7日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •Thai liver transplant patients (cadaveric liver transplant)
- •Aged 18 years or older
排除标准
- •Thai liver transplant patients (Living liver transplant)
研究者
相似试验
进行中（未招募）
1 期
The influence of CYP3A5 and ABCB1 genotype on the pharmacokinetics of twice daily Tacrolimus and Advagraf - Pharmacogenetics of twice daily Tacrolimus and AdvagrafRenal transplantation.MedDRA version: 14.1 Level: LLT Classification code 10023438 Term: Kidney transplant System Organ Class: 100000004865EUCTR2009-013461-25-GBSt. George's, University of London330
Enrolling By Invitation
不适用
Impact of CYP3A5 polymorphisms on intra-patient variability of tacrolimus pharmacokinetics in kidney transplant recipientsage over 18 years old,received immunosuppressive therapy based on twice-daily tacrolimus (Prograf®)tacrolimuspharmacokineticsintrapatient variabilityCYP3A5TCTR20180619003Chulalongkorn University200
尚未招募
不适用
Impact of CYP2A6 and CHRM3 genetic polymorphisms on the PK/PD of pilocarpine in Japanese healthy volunteerss syndromeSjogren's syndromeJPRN-UMIN000010796Oita University Faculty of Medicine30
已完成
不适用
Healthy Volunteer CYP3A5 Genotype studyCTRI/2018/10/016104ithya Gogtay400
已完成
不适用
The Effect of genetic polymorphism of CYP2B6 and UGT1A9 on the Pharamcokinetics and Pharmacodynamics of PropofolThe patients are surgical operation with propofol in the St. Marianna University HospitalJPRN-UMIN000002009St. Marianna University School of Medicine, Department of Pharmacogenomics100